Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-39 Cr₹-441 Cr₹-422 Cr₹818 Cr₹794 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-39 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-39 Cr
Mar2025₹-441 Cr
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-39 Cr
Negative
Mar2025 ₹-441 Cr
Negative
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹32,643.5 Cr 2.5% 25% 23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,707.0 Cr 1.4% 6.7% 12% Stock Analytics
DIVIS LABORATORIES ₹303,962.0 Cr 11.1% 23.5% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,494.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹115,769.0 Cr 1.1% 11.8% 14.2% Stock Analytics
CIPLA ₹113,912.0 Cr 0.1% 6% -5.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.5%

25%

23.2%

SENSEX

3.3%

13.9%

-1.7%


You may also like the below Video Courses